PHC-12-2015-1
PHC-12-2015-1
87 projects · €4,350,000 total EU contribution (project-level) · 88 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€4,350,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (12)
- Germany (11)
- Spain (11)
- Italy (11)
- SE (8)
- France (6)
- IL (6)
- DK (4)
- AT (3)
- HU (3)
- IE (2)
- Netherlands (2)
- BE (1)
- BG (1)
- EE (1)
- FI (1)
- IS (1)
- NO (1)
- PT (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AETHRA TELECOMMUNICATIONS1 projects · IT
- ACONET1 projects · IT
- ADAPTIX1 projects · UK
- BIFARMA1 projects · HU
- ALAM MEDICAL1 projects · FR
- ANANDA PHARMA1 projects · DE
- ANAXSYS TECHNOLOGY LTD1 projects · UK
- ANGIOTARGET BV1 projects · NL
- AROCELL AB1 projects · SE
- ATTOMARKER LIMITED1 projects · UK
- Atturos1 projects · IE
- AVERBIS GMBH1 projects · DE
Projects
Page 9 of 9
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Validation of diagnostic and prognostic biomarkers for Parkinson disease Biomarkers for PD · 697790 | H2020 | €50,000 | €71,429 | Details |
OsteomiR-Test – An In-Vitro Test for the Diagnosis of Osteoporosis and associated Fracture Risk OsteomiR · 683435 | H2020 | €50,000 | €71,429 | Details |
Feasibility study on Opto-Magnetic Imaging Spectroscopy for cancer screening OMIS · 717525 | H2020 | €50,000 | €71,429 | Details |
Predictive in vitro diagnostics test for individualized tailoring of chemotherapy in primary breast cancer ChemoPredict · 683469 | H2020 | €50,000 | €71,429 | Details |
Augmented Reality Vision for Surgery ARVisS · 697613 | H2020 | €50,000 | €71,429 | Details |
Blood Biomarker Array Technology LIBERATE · 684366 | H2020 | €50,000 | €71,429 | Details |
CIRDvalid – Clinical validation of a set of 11 biomarkers and a system of diagnostic and therapeutical devices for the resuscitation of patients suffering from long-lasting cardiac arrest CIRDvalid · 681240 | H2020 | €50,000 | €71,429 | Details |